MEGAN LAWSON: Open Payments
NPI 1457927386 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 57 payments from 11 companies in 2025. Trend: 2023 $821 · 2024 $864 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 21 | $221 |
| Lundbeck LLC | 14 | $176 |
| Corium, LLC | 5 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Alkermes, Inc. | 2 | $48 |
| ABBVIE INC. | 3 | $47 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $19 |
Products named: Qelbree, REXULTI, Azstarys, FANAPT, Auvelity, SPRAVATO, ARISTADA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
